Literature DB >> 18657420

Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part II: Folic acid conjugates of tubulysins and their hydrazides.

Iontcho R Vlahov1, Yu Wang, Paul J Kleindl, Christopher P Leamon.   

Abstract

Efficient syntheses of folate conjugates of tubulysins and their hydrazides 1a-d are described. These water soluble folate receptor (FR) targeted conjugates are derivatives of folic acid and the potent cytotoxic agents: tubulysin A, B, or their respective hydrazides, connected in regioselective manner via a hydrophilic peptide spacer and a reducible disulfide linker.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657420     DOI: 10.1016/j.bmcl.2008.07.041

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

Review 1.  Optimising the delivery of tubulin targeting agents through antibody conjugation.

Authors:  Gary D Stack; John J Walsh
Journal:  Pharm Res       Date:  2012-07-10       Impact factor: 4.200

2.  Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice.

Authors:  William C Floyd; Gopal K Datta; Shinichi Imamura; Heidi M Kieler-Ferguson; Katherine Jerger; Andrew W Patterson; Megan E Fox; Francis C Szoka; Jean M J Fréchet; Jonathan A Ellman
Journal:  ChemMedChem       Date:  2011-01-03       Impact factor: 3.466

3.  Targeted delivery of mPGES-1 inhibitors to macrophages via the folate receptor-β for inflammatory pain.

Authors:  Liudmila L Mazaleuskaya; Seokwoo Lee; Hu Meng; Jeffrey D Winkler; Garret A FitzGerald
Journal:  Bioorg Med Chem Lett       Date:  2021-08-12       Impact factor: 2.940

4.  Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.

Authors:  Michal Stark; Yehuda G Assaraf
Journal:  Oncotarget       Date:  2017-07-25

5.  1,3-Dichloroacetone: A Robust Reagent for Preparing Bicyclic Peptides.

Authors:  Qingqing Lin; Denham Hopper; Haoyue Zhang; Jordan Sfyris Qoon; Zihan Shen; John A Karas; Richard A Hughes; Susan E Northfield
Journal:  ACS Omega       Date:  2020-01-17

6.  Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic.

Authors:  Joseph A Reddy; Ryan Dorton; Alicia Bloomfield; Melissa Nelson; Christina Dircksen; Marilynn Vetzel; Paul Kleindl; Hari Santhapuram; Iontcho R Vlahov; Christopher P Leamon
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.